Viewing Study NCT06169202


Ignite Creation Date: 2025-12-25 @ 3:44 AM
Ignite Modification Date: 2026-02-27 @ 10:32 AM
Study NCT ID: NCT06169202
Status: RECRUITING
Last Update Posted: 2023-12-13
First Post: 2023-12-05
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Fruquintinib in Combination With Irinotecan and Capecitabine for the Second-line Treatment of Patients
Sponsor: China Medical University, China
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module